Multi-kinase inhibitor 4 (compound 14) serves as an orally effective inhibitor targeting FLT1, KDR, FLT3, FLT4, PDGFRalpha, and PDGFRbeta, exhibiting IC50 values of 1.97 nM, 1.04 nM, 0.33 nM, 1.44 nM, 0.18 nM, and 0.89 nM respectively. This compound plays a crucial role in cancer research.
Molecular Weight:
440.5
CAS Number:
[2648279-77-8]
Formula:
C25H24N6O2
Target:
FLT|||PDGFR
T201144
* VAT and and shipping costs not included. Errors and price changes excepted